Acrivon Therapeutics Files 8-K on Financials and Operations
Ticker: ACRV · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1781174
| Field | Detail |
|---|---|
| Company | Acrivon Therapeutics, Inc. (ACRV) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, disclosure
Related Tickers: ACRV
TL;DR
ACRV filed an 8-K detailing financial results and operations as of March 25, 2025.
AI Summary
On March 25, 2025, Acrivon Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with disclosures related to Regulation FD and other events. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing provides crucial updates on Acrivon Therapeutics' financial health and operational status, which are key indicators for investors and stakeholders.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and operational updates, not indicating any immediate material adverse events.
Key Players & Entities
- Acrivon Therapeutics, Inc. (company) — Registrant
- 0000950170-25-044549 (other) — Accession Number
- March 25, 2025 (date) — Filing Date
- 480 Arsenal Way, Suite 100, Watertown, MA 02472 (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Acrivon Therapeutics?
The primary purpose of this 8-K filing is to report on Acrivon Therapeutics' results of operations and financial condition, as well as to provide Regulation FD disclosures and report on other events.
When was this 8-K report filed?
This 8-K report was filed on March 25, 2025.
What is Acrivon Therapeutics' principal executive office address?
Acrivon Therapeutics' principal executive office is located at 480 Arsenal Way, Suite 100, Watertown, Massachusetts 02472.
What is the Commission File Number for Acrivon Therapeutics?
The Commission File Number for Acrivon Therapeutics is 001-41551.
What standard industrial classification is Acrivon Therapeutics listed under?
Acrivon Therapeutics is listed under the standard industrial classification of Pharmaceutical Preparations [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Acrivon Therapeutics, Inc. (ACRV).